Skip to main content
Tech.euFundingExplorerBeta

VIVES Louvain Technology Fund

Investor profile

Venture capital

VIVES Louvain Technology Fund has backed 1 European tech company across 2 funding rounds between 2021 and 2022, joining rounds totalling €59M. Most active in Healthtech. Data as of 4 Nov 2026.

Deals
2
distinct rounds
Companies
1
backed
Active span
2021–2022
2 yrs
Total round €
€59M
sum of rounds joined

Deals by year

distinct rounds / year
VIVES Louvain Technology Fund — deals by year — interactive chart.
Data table
VIVES Louvain Technology Fund — deals by year
20211
20221

Top sectors

by deals
VIVES Louvain Technology Fund — top sectors — interactive chart.
Data table
VIVES Louvain Technology Fund — top sectors
Healthtech2

Stages

by deals
VIVES Louvain Technology Fund — stages — interactive chart.
Data table
VIVES Louvain Technology Fund — stages
Series B2

Countries

by deals
VIVES Louvain Technology Fund — countries — interactive chart.
Data table
VIVES Louvain Technology Fund — countries
Belgium2

Co-investment network

shared rounds
Co-investment network — interactive chart.
VIVES Louvain Technology Fund — 2 dealsVIVES Louvain Technology FundCR-CP Life Science Fund — 2 shared deals · click to openCR-CP Life Science FundFundPlus — 2 shared deals · click to openFundPlusInvestSud — 2 shared deals · click to openInvestSudNew Science Ventures — 2 shared deals · click to openNew Science VenturesSRIW Life Sciences — 2 shared deals · click to openSRIW Life SciencesInvest.BW — 1 shared deals · click to openInvest.BWOlivier van der Rest — 1 shared deals · click to openOlivier van der RestPierre Drion — 1 shared deals · click to openPierre DrionWalloon Region — 1 shared deals · click to openWalloon Region

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Novadip BiosciencesBelgium2€59M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Novadip BiosciencesSeries B€40M2022-11
Novadip BiosciencesSeries B€19M2021-11
← Back to investors